|
|
Home
The Word Brain
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Cervical Cancer |
| Single Articles |
AMEDEO Cervical Cancer is free of charge.
Gelatin-PVA Hydrogel Composite-Based Immunosensing Interface for Early Detection
of HPV16-Driven Cervical Cancer.
ACS Appl Bio Mater. 2026 Sep 1. doi: 10.1021/acsabm.6c01028.
PubMed
Abstract available
Integrating a "see-and-treat" approach with opportunistic human papilloma virus
deoxyribonucleic acid (HPV DNA) based cervical cancer screening in India: a
retrospective cross-sectional study.
AJOG Glob Rep. 2026;6:100678.
PubMed
Abstract available
Identification of Risk Factors and Development of a Prediction Model for
Postoperative Urinary Retention Following Radical Hysterectomy for Cervical
Cancer Based on Preoperative Urodynamic Profiling.
Arch Esp Urol. 2026;79:1162-1170.
PubMed
Abstract available
Nurse-led interventions for cervical cancer patients: A scoping review with an
emphasis on East Asian contexts.
Belitung Nurs J. 2026;12:424-437.
PubMed
Abstract available
Harnessing necroptosis via RIPK1 degradation to potentiate radio-immunotherapy in
cervical cancer.
Bioact Mater. 2026;67:703-718.
PubMed
Abstract available
Biochim Biophys Acta Mol Basis Dis
EGFR and PGE2 signaling pathways mutually cooperate to promote pro-tumorigenic
effects in cervical cancer.
Biochim Biophys Acta Mol Basis Dis. 2026;1873:168443.
PubMed
Abstract available
Transcriptomics and single-cell RNA sequencing uncover prognostic characteristics
and immune regulatory mechanisms of lactylation in cervical cancer.
Bioimpacts. 2026;16:33527.
PubMed
Abstract available
Is active surveillance of CIN2 always appropriate? Clinical outcomes and factors
associated with progression and regression over 48 months in an HPV-positive
cohort.
BMC Cancer. 2026 Jun 22. doi: 10.1186/s12885-026-16398.
PubMed
Abstract available
Projections of human papillomavirus (HPV) vaccination impact on non-cervical
cancer outcomes among women in 117 low- and middle-income countries: a modelling
study.
BMJ Glob Health. 2026;11:e021127.
PubMed
Abstract available
The Effect of Breastfeeding on Cervical Dysplasias.
Breastfeed Med. 2026;21:541-547.
PubMed
Abstract available
Cervical cancer in French Guiana before the implementation of the University
Hospital: Outcome and prognosis.
Bull Cancer. 2026 Sep 2:S0007-4551(26)00397-8. doi: 10.1016/j.bulcan.2026.
PubMed
Abstract available
Can we eliminate cervical cancer in Canada? In conversation with leading experts
in public health and cancer prevention.
Can J Public Health. 2026 Sep 2. doi: 10.17269/s41997-026-01247.
PubMed
Assessing the Capacity of Health Facilities to Deliver Concomitant HPV
Vaccination and HPV-Based Cervical Screening Services to Vulnerable Populations -
An Implementation Research Protocol.
Cancer Control. 2026;33:10732748261475365.
PubMed
Abstract available
CTGF/CCN2 Promotes Invasive Growth in Cervical Cancer Spheroids and Is Associated
With Metastatic Cervical Cancer Tissue.
Cancer Genomics Proteomics. 2026;23:934-947.
PubMed
Abstract available
Comparative Analysis of Breast and Cervical Screening Adaptability at a Federally
Qualified Health Center.
Cancer Prev Res (Phila). 2026;19:529-540.
PubMed
Abstract available
Efficacy and Safety of Immune Checkpoint Inhibitors for Recurrent or Metastatic
Cervical Cancer: A Systematic Review and Meta-Analysis.
Curr Gene Ther. 2026 Aug 22. doi: 10.2174/0115665232459323260803060556.
PubMed
Abstract available
Turnaround Time Trends in Cervical Cytology Screening in South Africa, 2005-2023.
Diagn Cytopathol. 2026;54:755-763.
PubMed
Abstract available
Complications, recurrence, and survival rates for endometrial and cervical cancer
treated by minimally invasive surgery: a systematic review and meta-analysis of
randomised controlled trials.
Facts Views Vis Obgyn. 2026 Aug 31. doi: 10.52054/FVVO.2026.
PubMed
Abstract available
The implications and mechanisms of vaginal microbiota metabolites on cervical
cancer progression.
Front Cell Infect Microbiol. 2026;16:1886165.
PubMed
Abstract available
Elevated neutrophil extracellular traps formation driven by the HPV-mediated
CXCL8-CXCR1/2-ROS-p21 axis promotes the growth and metastasis of cervical cancer.
Front Immunol. 2026;17:1861481.
PubMed
Abstract available
Serplulimab combined with bevacizumab and chemotherapy as first-line treatment
for recurrent or metastatic cervical cancer (ASTRUM-CC01): a phase II trial.
Front Immunol. 2026;17:1923961.
PubMed
Abstract available
Real-world efficacy and safety profile of low-dose cadonilimab in recurrent or
metastatic cervical cancer as first-line therapy.
Front Immunol. 2026;17:1871890.
PubMed
Abstract available
Cervical cancer patients' vaginal microbiome and metabolites: research progress
and clinical applications.
Front Microbiol. 2026;17:1891111.
PubMed
Abstract available
ERalpha36 is associated with SLC7A5/LAT1 expression, cervical cancer progression, and
BNCT response: a translational study.
Front Oncol. 2026;16:1902977.
PubMed
Abstract available
Virtual MR elastography and continuous-time random walk for predicting Ki-67
status in cervical cancer: a preliminary study.
Front Oncol. 2026;16:1843126.
PubMed
Abstract available
Correction: Effect of bladder volume on dose of exposure to dangerous organs and
incidence of cystitis and enteritis in patients with cervical cancer after
external radiotherapy.
Front Oncol. 2026;16:1959912.
PubMed
Abstract available
Access to cervical cancer care in sub-Saharan Africa: a narrative review of
barriers and opportunities.
Front Public Health. 2026;14:1881652.
PubMed
Abstract available
HPV52 predominates in cervical infections and precancerous lesions in Chongqing,
China: a 6-year study linking genotypes to vaginal microecology.
Front Public Health. 2026;14:1879232.
PubMed
Abstract available
Women's autonomy and discrimination relevant to cervical cancer screening.
Front Reprod Health. 2026;8:1837034.
PubMed
Abstract available
Charting host structural variations in cervical cancer by long-read sequencing
pinpoints a functional deletion in PIAS1.
Genomics. 2026;118:111311.
PubMed
Abstract available
Evaluating the cost-effectiveness of implementing HPV vaccination in Turkiye's
National Immunization Program using the PRIME model.
Ginekol Pol. 2026;97:641-646.
PubMed
Abstract available
Prognostic value of the nutritional risk index and prognostic nutritional index
for immunotherapy outcomes in cervical Cancer.
Gynecol Oncol Rep. 2026;67:102184.
PubMed
Abstract available
Knowledge, Attitudes, and Uptake of Cervical Cancer Screening Among Female
Students and Staff at a Tertiary Institution in Northern Uganda: A
Cross-Sectional Study.
Health Sci Rep. 2026;9:e73191.
PubMed
Abstract available
Guardians' willingness to vaccinate primary and secondary school girls against
human papillomavirus and associated factors in ethnic autonomous prefectures of
Qinghai Province, China: A cross-sectional study based on the Health Belief Model
and Theory
Hum Vaccin Immunother. 2026;22:2725492.
PubMed
Abstract available
Near-peer education by medical students and its association with HPV vaccination
knowledge and attitudes among Japanese adolescents: An exploratory intervention
study.
Hum Vaccin Immunother. 2026;22:2724650.
PubMed
Abstract available
HPV vaccine uptake in Pakistan: A qualitative study to identify barriers and
facilitators before the first HPV national rollout.
Hum Vaccin Immunother. 2026;22:2721105.
PubMed
Abstract available
HPV genotype distribution and associated risk factors in women from Karad,
Maharashtra: A molecular characterisation study.
Indian J Med Res. 2026;164:493-495.
PubMed
Abstract available
Stage-specific lipidomic signatures as biomarkers in progression of cervical
cancer.
Indian J Med Res. 2026;164:349-356.
PubMed
Abstract available
HPV Genotype Distribution in Cervical Cancer and High-Grade Lesions in Norway,
and Early Vaccine Impact.
Int J Cancer. 2026 Aug 28. doi: 10.1002/ijc.70712.
PubMed
Abstract available
Application of small-pelvic adjuvant radiotherapy in early cervical cancer
without high-risk factors after hysterectomy.
Int J Gynecol Cancer. 2026 Aug 29:104952. doi: 10.1016/j.ijgc.2026.104952.
PubMed
Abstract available
Diagnostic accuracy of Chronic Kidney Disease Epidemiology Collaboration 2021 and
Janowitz-estimated glomerular filtration rate for identifying renal dysfunction
compared with 99mTc-DTPA in patients with locally advanced cervical cancer.
Int J Gynecol Cancer. 2026 Aug 13:104969. doi: 10.1016/j.ijgc.2026.104969.
PubMed
Abstract available
Patient-reported outcomes with tisotumab vedotin versus chemotherapy in patients
with recurrent or metastatic cervical cancer: post hoc analyses from the
open-label, randomized, phase 3 ENGOT-cx12/GOG-3057/innovaTV 301 trial.
Int J Gynecol Cancer. 2026 Aug 11:104947. doi: 10.1016/j.ijgc.2026.104947.
PubMed
Abstract available
Toward Optimal Fractionation Schemes in Non-uniform Radiotherapy: Exploiting
Helical Tomotherapy's Thread Effect for Gynecological Cancer Treatment.
Int J Radiat Oncol Biol Phys. 2026 Mar 24:S0360-3016(26)00508.
PubMed
Abstract available
Costs of HPV vaccination programs in low- and middle-income countries: A
systematic review.
J Cancer Policy. 2026;49:100767.
PubMed
Abstract available
Promoting the HPV vaccine across the league of Arab states: A scoping review of
interventions.
J Cancer Policy. 2026;49:100770.
PubMed
Abstract available
The prevalence of human papillomavirus infection among women in primary health
care, Santiago, Chile (2015-2024).
J Cancer Policy. 2026;49:100776.
PubMed
Abstract available
Causal inference, cancer registry data, and a single state policy change:
Evaluating Virginia's HPV vaccine mandate.
J Cancer Policy. 2026;49:100777.
PubMed
Abstract available
Interventions to increase cervical screening rates for women with intellectual
and developmental disabilities: a scoping review.
J Intellect Dev Disabil. 2026;51:350-360.
PubMed
Abstract available
Volumetric and Geometric Assessment of Offline Adaptation in Cervical Cancer
External Beam Radiotherapy.
J Med Imaging Radiat Oncol. 2026 Sep 1. doi: 10.1111/1754-9485.70171.
PubMed
Abstract available
Developments in human papillomavirus vaccines, schedules, and implementation
strategies.
J Natl Cancer Inst Monogr. 2026;2026:137-147.
PubMed
Abstract available
Benefits, harms, and cervical cancer elimination timing of human papillomavirus
screening approaches tailored to birth cohort as a proxy for vaccination status
in the United States: a comparative modeling study.
J Natl Cancer Inst Monogr. 2026;2026:126-136.
PubMed
Abstract available
From evidence to practice: leveraging implementation science for transitioning to
risk-adapted cervical cancer screening.
J Natl Cancer Inst Monogr. 2026;2026:194-203.
PubMed
Abstract available
Cervical cancer screening in vaccinated populations: challenges and implications
for low- and middle-income countries.
J Natl Cancer Inst Monogr. 2026;2026:155-163.
PubMed
Abstract available
Evidence for type replacement as a consequence of vaccination and implications
for cervical screening.
J Natl Cancer Inst Monogr. 2026;2026:148-154.
PubMed
Abstract available
The need to change cervical cancer screening in the post-human papillomavirus
vaccination era: the interplay between disease prevalence and risk, test
characteristics, and efficiency of screening programs.
J Natl Cancer Inst Monogr. 2026;2026:118-125.
PubMed
Abstract available
Effective communications to support risk-adapted cervical screening in human
papillomavirus-vaccinated women: lessons learned and ways forward.
J Natl Cancer Inst Monogr. 2026;2026:187-193.
PubMed
Abstract available
How practically feasible is tailored screening for cervical cancer based on human
papillomavirus vaccination status?: the role of data linkage and registers.
J Natl Cancer Inst Monogr. 2026;2026:180-186.
PubMed
Abstract available
How to evaluate and select cervical screening and triage tests in vaccinated
populations.
J Natl Cancer Inst Monogr. 2026;2026:164-172.
PubMed
Abstract available
Deintensification of cervical cancer screening in the era of high human
papillomavirus-vaccination coverage.
J Natl Cancer Inst Monogr. 2026;2026:173-179.
PubMed
Abstract available
Intrathecal Chemotherapy Through Ommaya Reservoir in Leptomeningeal Metastasis
From Cervical Cancer: A Rare Case Report and Literature Review.
J Obstet Gynaecol Res. 2026;52:e70490.
PubMed
Abstract available
Development and Application of a Psychological Expectations Scale for Patients
With Middle- and Late-Stage Cervical Cancer in China.
J Obstet Gynaecol Res. 2026;52:e70481.
PubMed
Abstract available
DNA Methylation Testing in Cervical Cancer: A Triage Tool for HPV-Based Screening
and Post-Treatment Surveillance.
J Obstet Gynaecol Res. 2026;52:e70473.
PubMed
Abstract available
Artificial intelligence-assisted histopathological diagnosis of endocervical
gastric-type adenocarcinoma: a multicenter model development and validation
study.
J Pathol Clin Res. 2026;12:e70113.
PubMed
Abstract available
Perceived Feasibility and Acceptability of a Self-Collected HPV DNA Testing
Policy for Cervical Cancer Screening in Thailand.
J Prim Care Community Health. 2026;17:21501319261486985.
PubMed
Abstract available
Applying an AI Decision Support Device During Cervical Cancer Screening in
Bangladesh and Uganda: Implementation Study.
JMIR Form Res. 2026;10:e81493.
PubMed
Abstract available
Cancer screening programmes in the Czech Republic and their results.
Klin Onkol. 2026;39.
PubMed
Abstract available
Chrysin treatment is associated with altered microrna expression and reduced
levels of HPV16 E6 protein in caski cervical cancer cells.
Med Oncol. 2026;43:257.
PubMed
Abstract available
Postoperative Sexual Quality of Life and Associated Factors After Loop
Electrosurgical Excision Procedure Versus Cold Knife Conization in 185 Sexually
Active Women With Preinvasive Cervical Lesions.
Med Sci Monit. 2026;32:e954246.
PubMed
Abstract available
High diagnostic concordance between vulvar and cervical samples for human
papillomavirus detection: a cross-sectional study.
Microbiol Spectr. 2026;14:e0402625.
PubMed
Abstract available
Interaction of circular RNAs with splicing factors in cervical cancer:
Modulation, interplay and theranostics (Review).
Mol Med Rep. 2026;34:295.
PubMed
Abstract available
CLCF1-ZIC5-CNTFR feedback loop drives cisplatin resistance in cervical squamous
cell carcinoma.
Neoplasia. 2026;80:101342.
PubMed
Abstract available
Cervical Cancer Screening Utilization and Its Correlates Among Women of
Reproductive Age in North Central Nigeria: A Cross-Sectional Study.
Niger Med J. 2026;67:1463-1472.
PubMed
Abstract available
Enhancing Patient Participation in Follow-Up Care for Cervical Cancer Screening
Abnormalities: A Cervical Health Facilitator Pilot Project.
Nurs Womens Health. 2026 Sep 4:S1751-4851(26)00173.
PubMed
Abstract available
Understanding the association between immune-modulating helminths and HPV or
cervical cancer: A scoping review.
PLoS Negl Trop Dis. 2026;20:e0013308.
PubMed
Abstract available
Understanding retention in longitudinal surveys conducted by mobile phone in
lower-resource contexts: A case study from Kenya.
PLoS One. 2026;21:e0354780.
PubMed
Abstract available
Dosimetric Comparison of Fixed-Configuration Versus Image Guided Needle Insertion
in Cervical Brachytherapy.
Pract Radiat Oncol. 2026;16:e427-e434.
PubMed
Abstract available
Effects of a Message-Framing Video Intervention on Maternal Vaccine Confidence
Regarding HPV Vaccination for Daughters: A Quasi-Experimental Study Among Mothers
With Cervical Intraepithelial Neoplasia.
Public Health Nurs. 2026;43:1316-1325.
PubMed
Abstract available
Supportive care needs among patients with breast and cervical cancer at a
tertiary cancer treatment center in ethiopia: a cross-sectional study.
Sci Rep. 2026;16:27555.
PubMed
Abstract available
Infection and alpha-ketoglutarate/oxygen inhibition converge to CDC20 to promote
cancer cell aneuploidy.
Signal Transduct Target Ther. 2026;11:364.
PubMed
Abstract available
Experiences and challenges of North Korean defectors with cervical cancer: a
qualitative study using thematic analysis.
Support Care Cancer. 2026;34:926.
PubMed
Abstract available
HPV Integration as a Triage Tool for HPV-Positive Women in Cervical Cancer
Screening.
Tumour Virus Res. 2026 Sep 1:200351. doi: 10.1016/j.tvr.2026.200351.
PubMed
Abstract available
[Mechanism study on baicalein inhibiting cervical cancer driven by persistent HPV
infection via restoring MAVS-IRF3-IFN-beta mitochondrial antiviral signal].
Zhongguo Zhong Yao Za Zhi. 2026;51:4493-4501.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
